User:Mr. Ibrahem/Ibrexafungerp

Ibrexafungerp, sold under the brand name Brexafemme, is an antifungal medication used to treat vaginal yeast infection. It may be used in females after the start of menstruation. It is taken by mouth.

Common side effects include diarrhea, nausea, abdominal pain, and dizziness. Use in pregnancy may harm the baby. It is a triterpenoid antifungal and acts via blocking glucan synthase, which prevents formation of the fungal cell wall.

Ibrexafungerp was approved for medical use in the United States in 2021. It is not approved in Europe or the United Kingdom as of 2022. In the United States a course of treatment costs about 500 USD as of 2022.